Measure 418 – Osteoporosis Management in Women Who Had a Fracture

Audit Criteria

When we’re reviewing your clinicians’ data, it may be helpful to know what we are looking for in order for us to verify to CMS that your data is accurate and complete. Measure 418 requires documentation that a patient received a bone mineral density test (DXA) or a prescription for a drug to treat osteoporosis in the six months following a fracture (excluding fractures of the fingers, toes, face, or skull).


This documentation may be found in the patient’s medical record. The relevant document (i.e. test results or orders for a prescription to treat osteoporosis) should be made available to the auditor for the patient requested.